AI Approach Identifies Potential New Drugs to Treat COVID-19
A machine-learning approach screened millions of commercially available small moleculesto identify hundreds of potential drug candidates to treat COVID-19.
Related Articles
PathAI, Google Cloud Partner to Provide AI-Based Image Management to Pathology Labs
Under the terms of the agreement, PathAI will make its AISight image management system available to pathology labs on the Google Cloud.
SCG Cell Therapy and A*STAR Collaborate on Scalable GMP Manufacturing of Cellular Immunotherapies
SCG says it has developed in-house cGMP manufacturing capabilities to supply high-quality cell therapy products to patients.
Xenotransplantation of 10GE Pig Kidneys to NHPs Shows Consistent Survival
Kidney xenotransplantation from pigs with 10 genetic modifications (10GE pigs) to non-human primates (NHPs) showed consistent survival rates.
Visual Proteomics: Observing Protein Location in Living Cells
The vpCells approach enables researchers to fluorescently label five different proteins in living cells.
Blood Biomarker Reveals Signs of Multiple Sclerosis Years Before
University of California, San Francisco (UCSF) scientists have discovered a precursor in the blood of some people who later went on to develop multiple sclerosis…
Cytiva Introduces Its Xcellerex Magnetic Mixer at Interphex
Cytiva notes that its magnetic mixing system can meet the many demands and constraints during buffer and cell culture media preparation.
Accelerating Progress in Cell and Gene Therapy
Azenta Life Sciences addresses cryopreservation scalability and standardization challenges.
Asahi Kasei and Axolabs Partner on Oligonucleotide Therapeutics
Asahi Kasei and Axolabs will collaborate to build an oligo GMP manufacturing facility spanning an area of 59,000 square feet in Berlin.
Merck Launches All-in-One Genetic Stability Assay for Biosafety Testing
Currently, FDA guidance requires biotech companies to use multiple assays to address genetic stability requirements. This traditional package of assays is costly, time-consuming, and often…
Model Predicts RTD—with Variations—for Continuous Processing
Regulators advise resident time distribution (RTD) studies as a way to address issues between batch processing and continuous manufacturing of biologics.